CELADON PHARMACEUTICALS PLC
Researches, cultivates, and manufactures cannabinoid-based medicines for chronic pain.
CEL | IL
Overview
Corporate Details
- ISIN(s):
- GB00BDQYGP38
- LEI:
- 213800YXCATORT475807
- Country:
- United Kingdom
- Address:
- 32-33 COWCROSS STREET, EC1M 6DF LONDON
- Website:
- https://celadonpharma.co.uk/
- Sector:
- Manufacturing
Description
Celadon Pharmaceuticals PLC is a vertically integrated pharmaceutical company focused on the research, cultivation, manufacturing, and supply of cannabinoid-based medicines. The company operates a licensed, 100,000 sq ft facility with EU-GMP certification for the indoor, hydroponic cultivation of high-THC cannabis and the extraction of cannabinoid Active Pharmaceutical Ingredients (API). Its primary focus is the chronic pain market, and it is conducting an MHRA conditionally approved clinical trial to generate data supporting the use of its medicines for this condition. Additionally, Celadon has an in-house research and development program focused on intellectual property generation and is involved in developing a licensed cannabinoid treatment for Autism Spectrum Disorder through a biopharma partnership.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-06-03 18:45 |
Publication of Annual Report & Notice of AGM
|
English | 12.3 KB | ||
| 2024-05-23 08:00 |
Supply of Products to New US Customer
|
English | 14.3 KB | ||
| 2024-05-15 15:45 |
Exercise of Share Options and Total Voting Rights
|
English | 12.8 KB | ||
| 2024-05-14 08:00 |
Final Results
|
English | 735.4 KB | ||
| 2024-05-10 08:00 |
Fundraise, RCF Extension, Termination of CLN & TVR
|
English | 19.7 KB | ||
| 2024-03-07 08:00 |
Early Economic Analysis of Feasibility Study Data
|
English | 18.0 KB | ||
| 2023-12-14 08:00 |
Product Supplied to First Two Sales Contracts
|
English | 15.8 KB | ||
| 2023-12-12 15:00 |
Fundraise, Update on Future CLN Financing & TVR
|
English | 18.6 KB | ||
| 2023-11-16 08:00 |
New European Sales Contract
|
English | 16.3 KB | ||
| 2023-10-13 08:00 |
Fundraise, CLN Issue, Joint Broker Appointed & TVR
|
English | 18.6 KB | ||
| 2023-09-28 08:00 |
Interim Results
|
English | 383.2 KB | ||
| 2023-09-18 08:00 |
Notice of Results and Investor Presentation
|
English | 11.7 KB | ||
| 2023-09-05 08:00 |
New Sales Contract with UK Pharmaceutical Company
|
English | 13.7 KB | ||
| 2023-08-01 08:00 |
Approval to roll-out chronic pain clinical trial
|
English | 14.5 KB | ||
| 2023-06-29 18:30 |
Result of AGM
|
English | 11.5 KB |
Automate Your Workflow. Get a real-time feed of all CELADON PHARMACEUTICALS PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for CELADON PHARMACEUTICALS PLC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for CELADON PHARMACEUTICALS PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
